Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Currently, insufficient data exist to evaluate the relationship between angiographic late loss (LL) and long-term clinical outcome after drug-eluting stent (DES) implantation. In this study, we hypothesized that angiographic LL between 0.3 and 0.6 mm correlate with favorable long-term clinical outcomes. Materials and Methods: Patients were enrolled in the present study if they had undergone both DES implantation in single coronary vessel and a subsequent follow-up angiogram (n=634). These individuals were then subdivided into three groups based on their relative angiographic LL: group I (angiographic LL <0.3 mm, n=378), group II (angiographic LL between 0.3 and 0.6 mm, n=124), and group III (angiographic LL >0.6 mm, n=134). During a 5-year follow-up period, all subjects were tracked for critical events, defined as any cause of death or myocardial infarction, which were then compared among the three groups. Results: Mean follow-up duration was 63.0±10.0 months. Critical events occurred in 25 subjects in group I (6.6%), 5 in group II (4.0%), and 17 in group III (12.7%), (p=0.020; group I vs. group II, p=0.293; group II vs. group III, p=0.013). In a subsequent multivariate logistic regression analysis, chronic renal failure [odds ratio (OR)=3.29, 95% confidence interval (CI): 1.48-7.31, p=0.003] and long lesion length, defined as lesion length >28 mm (OR=1.88, 95% CI: 1.02-3.46, p=0.042) were independent predictors of long-term critical events. Conclusion: This retrospective analysis fails to demonstrate that post-DES implantation angiographic LL between 0.3 and 0.6 mm is protective against future critical events.
Abstract
Purpose: Currently, insufficient data exist to evaluate the relationship between angiographic late loss (LL) and long-term clinical outcome after drug-eluting stent (DES) implantation. In this study, we hypothesized that angiographic LL between 0.3 and 0.6 mm correlate with favorable long-term clinical outcomes. Materials and Methods: Patients were enrolled in the present study if they had undergone both DES implantation in single coronary vessel and a subsequent follow-up angiogram (n=634). These individuals were then subdivided into three groups based on their relative angiographic LL: group I (angiographic LL <0.3 mm, n=378), group II (angiographic LL between 0.3 and 0.6 mm, n=124), and group III (angiographic LL >0.6 mm, n=134). During a 5-year follow-up period, all subjects were tracked for critical events, defined as any cause of death or myocardial infarction, which were then compared among the three groups. Results: Mean follow-up duration was 63.0±10.0 months. Critical events occurred in 25 subjects in group I (6.6%), 5 in group II (4.0%), and 17 in group III (12.7%), (p=0.020; group I vs. group II, p=0.293; group II vs. group III, p=0.013). In a subsequent multivariate logistic regression analysis, chronic renal failure [odds ratio (OR)=3.29, 95% confidence interval (CI): 1.48-7.31, p=0.003] and long lesion length, defined as lesion length >28 mm (OR=1.88, 95% CI: 1.02-3.46, p=0.042) were independent predictors of long-term critical events. Conclusion: This retrospective analysis fails to demonstrate that post-DES implantation angiographic LL between 0.3 and 0.6 mm is protective against future critical events.
참고문헌 (18)
- Tu JV, "Effectiveness and safety of drug-eluting stents in Ontario", N Engl J Med, 357, pp.1393~1402 (2007)
- Stone GW, "Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents", N Engl J Med, 356, pp.998~1008 (2007)
- Daemen J, "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study", Lancet, 369, pp.667~678 (2007)
- Iakovou I, "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents", JAMA, 293, pp.2126~2130 (2005)
- Finn AV, "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization", Circulation, 115, pp.2435~2441 (2007)
- Kim BK, "Correlation of angiographic late loss with neointimal coverage of drug-eluting stent struts on follow-up optical coherence tomography", Int J Cardiovasc Imaging, 28, pp.1289~1297 (2012)
- 김웅, "The Initial Extent of Malapposition in ST-Elevation Myocardial Infarction Treated with Drug-Eluting Stent: The Usefulness of Optical Coherence Tomography", Yonsei Medical Journal, 51(3), pp.332~338 (2010), 연세대학교의과대학
- Pocock SJ, "Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials", J Am Coll Cardiol, 51, pp.23~32 (2008)
- Cutlip DE, "Clinical end points in coronary stent trials: a case for standardized definitions", Circulation, 115, pp.2344~2351 (2007)
- Mauri L, "Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents", Circulation, 111, pp.321~327 (2005)
- Brener SJ, "The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials", Atherosclerosis, 214, pp.158~162 (2011)
- Carter AJ, "Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model", Cardiovasc Res, 63, pp.617~624 (2004)
- Farb A, "Pathological analysis of local delivery of paclitaxel via a polymer-coated stent", Circulation, 104, pp.473~479 (2001)
- Nakazawa G, "One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis", JACC Cardiovasc Imaging, 2, pp.625~628 (2009)
- Nakazawa G, "The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents", J Am Coll Cardiol, 57, pp.1314~1322 (2011)
- Ko YG, "Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation", Int J Cardiovasc Imaging, 28, pp.715~723 (2012)
- Takano M, "Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel- and sirolimus-eluting stents", Circ Cardiovasc Interv, 1, pp.20~27 (2008)
- Rivero F, "Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents", EuroIntervention, 4, pp.124~132 (2008)